Major changes proposed for Canada’s patented drug pricing system
Friday, July 14, 2017 @ 9:42 AM | By Donalee Moulton
Rising drug prices may soon be a thing of the past. Health Canada has concluded a consultation on proposed regulatory amendments to the way patented drug prices are set that it is calling “the most significant suite of changes in over two decades.”
Timothy Squire, Fasken MartineauThe proposed amendments will shift the current landscape considerably for lawyers and their clients — and the directional is unilateral, said Timothy Squire, co-chair of Fasken Martineau’s international life sciences industry group in Toronto. “All the changes are designed to...
Timothy Squire, Fasken MartineauThe proposed amendments will shift the current landscape considerably for lawyers and their clients — and the directional is unilateral, said Timothy Squire, co-chair of Fasken Martineau’s international life sciences industry group in Toronto. “All the changes are designed to...
